Published: 1 June 2020
Author(s): Piero Portincasa, Marcin Krawczyk, Antonia Machill, Frank Lammert, Agostino Di Ciaula
Issue: July 2020
Section: Review Article

The outbreak of coronavirus disease 2019 (COVID-19) starting last December in China placed emphasis on liver involvement during infection. This review discusses the underlying mechanisms linking COVID-19 to liver dysfunction, according to recent available information, while waiting further studies. The manifestations of liver damage are usually mild (moderately elevated serum aspartate aminotransferase activities), and generally asymptomatic. Few patients can still develop severe liver problems, and therapeutic options can be limited.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.